Genotype-to-Phenotype Databased: A Holistic Solution (GEN2PHEN)
Research Areas
At a Glance
- Status: Completed Consortium
- Year Launched: 2008
- Initiating Organization: European Commission Seventh Framework Programme (FP7)
- Initiator Type: Government
- No disease focus
- Location: Europe
Abstract
The Genotype-to-Phenotype Databases (GEN2PHEN) consortium aims to create a web-based platform to capture and unify genetic information associated with health and disease progression. The consortium’s focus is to create an integrated genetic variation catalog for the research community, with a focus on disorders such as diabetes, obesity, heart disease, and cancer.
Mission
GEN2PHEN is a European-funded (Seventh Framework Programme) consortium focused on creating a database with human and model organism genetic variation data linked with other biomedical data sources via a genome browser functionality. It aims to create building blocks needed to create a complete biomedical knowledge environment, which will be used to construct a first-generation version of a genotype to phenotype (G2P) knowledge environment. This will consist of a European-centered but globally networked hierarchy of bioinformatics GRID-linked databases, tools, and standards, all tied into the Ensembl genome browser.
GEN2PHEN has the following specific objectives:
Financing
GEN2PHEN is funded by the Health Thematic Area of the Cooperation Programme of the European Commission within the Seventh Framework Programme for Research and Technological Development.
Links/Social Media Feed
Homepage |
|
|
Sponsors & Partners
BioBase GmbH, Germany |
Biocomputing Platforms Ltd Oy, Finland |
Commissariat à l’Energie Atomique, France |
Council of Scientific and Industrial Research, India |
deCODE genetics ehf, Iceland |
Erasmus University Medical Center, Netherlands |
European Molecular Biology Laboratory, Germany |
Foundation for Research and Technology – Hellas, Greece |
Fundació IMIM, Spain |
Institut National de la Santé et de la Recherche Médicale, France |
Institute for Molecular Medicine Finland, University of Helsinki, Finland |
Karolinska Institutet, Sweden |
Leiden University Medical Center, Netherlands |
University of Aveiro – IEETA, Portugal |
University of Leicester, UK |
University of Manchester, UK |
University of Patras, Greece |
University of Western Cape, South Africa |